Searched for
NATCO PHARMA US FDA APPROVAL
Risk is integral to the market; but there are different kinds of risk: 6 mid-cap stocks with upside potential of up to 21%We are in uncertain and volatile times. Does that mean investors should just sit out the downturn? While that is an option, the better opti...- US judge approves Anthropic's $1.5 billion settlement of copyright lawsuitU.S. District Judge Araceli Martinez-Olguin granted final approval of the settlement, the largest known settlement of a U.S. copyright case...
- Emcure Pharma gets CDSCO nod to market Poviztra for fatty liver treatmentEmcure Pharmaceuticals announced its brand Poviztra is now available for fatty liver treatment. This follows regulatory approval for treati...
- Takeda Biopharmaceuticals gets DCGI nod for dengue vaccine QDENGATakeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved for individua...
- Natco Pharma shares surge 5% after US FDA's tentative nod Olaparib tabletsNatco Pharma shares rose sharply on Monday after the U.S. FDA granted tentative approval for its generic Olaparib tablets, a bioequivalent ...
- Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at USD 1.4 bnAlembic Pharmaceuticals and NATCO Pharma received tentative USFDA approval for generic Olaparib tablets. This approval is for a cancer drug...
- Novo Nordisk's obesity drug Wegovy wins India approval to fight silent fatty liver killerIndia's drug regulator approved Novo Nordisk's Wegovy for MASH treatment. This drug targets a serious progressive form of fatty liver disea...
- Is Taylor Farms behind the 'Cyclosporiasis' outbreak in the US? California-based supplier's shredded iceberg lettuce reportedly linked to Taco BellHealth officials are investigating a cyclosporiasis outbreak affecting multiple US states. Taco Bell is removing lettuce from a supplier li...
- Merck gets US FDA nod for first-in-its-class oral cholesterol drugThe U.S. FDA has approved Merck's new cholesterol-lowering pill, Lipfendra. This oral medication works by blocking the PCSK9 protein, which...
- Sun Pharma gets SAHPRA approval for generic semaglutide injection in South Africa for type 2 diabetesSouth Africa's regulator approved Sun Pharma's generic semaglutide injection for diabetes. This approval allows marketing to supplement die...
- OneSource Specialty Pharma partners with Formycon AG to manufacture biosimilarsOneSource Specialty Pharma has announced a manufacturing partnership for biosimilars with Formycon AG. This collaboration will see OneSourc...
- Tired of ants taking over your home? This natural powder could help eliminate them without harsh chemicals in minutesDiatomaceous earth offers a natural solution for household pest problems. This fossilized diatom powder dehydrates insects, providing effec...
- Capitalmind Flexi Cap Fund drops Vedanta Power, Vedanta Iron & Steel and 8 other stocks in June. Check detailsCapitalmind Flexi Cap Fund completely exited 10 stocks, including Vedanta Power and Vedanta Iron and Steel, in June while adding seven new ...
- FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drugThe US FDA approved an at-home starting dose for Eisai and Biogen's Alzheimer's drug. This new subcutaneous formulation allows patients to ...
- What is CAR T-cell therapy? The 'living drug' that helped Sam Neill become cancer freeAcclaimed actor Sam Neill, famous for his Jurassic Park role, has passed away. His family confirmed his death on Monday, July 13, in Sydney...
- Maharashtra FDA bars sale of two Cadila drugs over branding concernsMaharashtra FDA has seized Cadila Pharmaceuticals drug stock worth Rs 2.45 crore. The action was taken due to similar branding on different...
- Circle shares surge 13% on getting regulatory approval to set up US trust bankCircle secured final regulatory approval from the OCC for its national trust bank. This allows the stablecoin issuer to manage its own rese...
- Stocks in news: TCS, Nalco, Maruti Suzuki, Natco Pharma, HFCLIndian markets saw a significant decline on Wednesday, influenced by global factors. TCS anticipates modest profit growth amid client spend...
- Natco Pharma to invest Rs 2,500 crore in South Africa expansionNatco Pharma will invest nearly Rs 2,500 crore in South Africa. This includes Rs 1,400 crore for its local subsidiary. The company will als...
- FDA issues modified risk orders for 20 ZYN nicotine pouch productsThe FDA has authorized Philip Morris International's ZYN nicotine pouches for reduced-risk marketing. This marks the first such approval fo...
Load More
